The major hypothesis guiding this grant has been that regulated synthesis of specific phosphoinositides at distinct cellular locations plays a critical role in cellular regulation. When this grant was initiated more than 10 years ago only two phosphorylated forms of phosphatidylinositol were known to exist in eukaryotic cells, PtdIns-4-P and PtdIns-4,5-P2 and these lipids were thought to be used exclusively for the generation of the second messengers Inositol-1,4,5-trisphosphate and Diacylglycerol. Largely through work supported by this grant, the total number of phosphoinositides known to exist in mammalian cells has expanded from two to seven and the number of families of phosphoinositide kinases has likewise expanded. It is now clear that many signaling proteins have evolved domains that directly bind to and discriminate between phosphoinositides as a mechanism of regulated recruitment to membranes. During the next funding period we will investigate how enzymes involved in PtdIns-4-P and PtdIns-4,5-P2 synthesis are located at specific subcellular sites and regulated by growth factors and hormones. However, we will place a major focus on a our surprising discovery of a new PtdIns-5-P signal transduction pathway in mammalian cells. The proposal has three specific aims. 1) We will determine how the PtdIns-5-P pathway is regulated by growth factors and other cellular regulators and determine its role in PtdIns-4,5-P2 production. We will explore the possibility that PtdIns-5-P is itself a second messenger. The gene encoding the PtdIns-5-P 4-kinase will be deleted in the mouse to determine the importance of this pathway at both the cell and animal level. 2) We will continue our efforts to define the types of PtdIns 4- kinases and focus on obtaining a cDNA clone of the major plasma membrane PtdIns 4-kinase of mammalian cells. 3) We will further investigate the regulation of Type I PtdIns-4-P 5-kinases and investigate their role in regulating actin remodeling at specific cellular locations.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM036624-16
Application #
6385627
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Ikeda, Richard A
Project Start
1992-12-01
Project End
2004-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
16
Fiscal Year
2001
Total Cost
$333,113
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Wong, Kwok-Kin; Engelman, Jeffrey A; Cantley, Lewis C (2010) Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 20:87-90
Myers, Andrea P; Meyerhardt, Jeffrey A; Cantley, Lewis C (2009) Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy? Clin Cancer Res 15:6748-50
Engelman, Jeffrey A; Chen, Liang; Tan, Xiaohong et al. (2008) Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med 14:1351-6
Chang, James D; Field, Seth J; Rameh, Lucia E et al. (2004) Identification and characterization of a phosphoinositide phosphate kinase homolog. J Biol Chem 279:11672-9
Nishikawa, K; Toker, A; Wong, K et al. (1998) Association of protein kinase Cmu with type II phosphatidylinositol 4-kinase and type I phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem 273:23126-33
Kapeller, R; Prasad, K V; Janssen, O et al. (1994) Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. J Biol Chem 269:1927-33
Yoakim, M; Hou, W; Songyang, Z et al. (1994) Genetic analysis of a phosphatidylinositol 3-kinase SH2 domain reveals determinants of specificity. Mol Cell Biol 14:5929-38
Liscovitch, M; Chalifa, V; Pertile, P et al. (1994) Novel function of phosphatidylinositol 4,5-bisphosphate as a cofactor for brain membrane phospholipase D. J Biol Chem 269:21403-6
Wong, K; Cantley, L C (1994) Cloning and characterization of a human phosphatidylinositol 4-kinase. J Biol Chem 269:28878-84
Carpenter, C L; Auger, K R; Chanudhuri, M et al. (1993) Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J Biol Chem 268:9478-83

Showing the most recent 10 out of 38 publications